Citation map · Study

SZodixStudyAcademic Library

Dashboard Shelves Open access My library Inbox Notes Write Learn Alerts

More

Ask your library Notifications Quick cite Review

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry

9 references·16 citing·46 second hop

FromToDepth

this work references cited by second hop

References

1991Entry and Competition in Concentrated Markets1,465 cited
1980The Role of Investment in Entry-Deterrence1,461 cited
1977Entry, Capacity, Investment and Oligopolistic Pricing1,147 cited
1980Product differentiation advantages of pioneering brands738 cited
1992Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act574 cited
1990Entry in Monopoly Markets528 cited
1991Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry399 cited
1998The Importance of the Physician in the Generic versus Trade-Name Prescription Decision300 cited
1988Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals254 cited

Cited by

2011Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration220 cited
2010Consumer learning and heterogeneity: Dynamics of demand for prescription drugs after patent expiration190 cited
2014Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States168 cited
2007Generic entry, price competition, and market segmentation in the prescription drug market161 cited
2010A DYNAMIC OLIGOPOLY STRUCTURAL MODEL FOR THE PRESCRIPTION DRUG MARKET AFTER PATENT EXPIRATION*

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

149 cited

2006Generic Competition in the US Pharmaceutical Industry145 cited

2016Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry124 cited

2006Reference pricing of pharmaceuticals124 cited

2004Price Competition in Pharmaceuticals: The Case of Anti‐infectives118 cited

2007Authorized Generic Drugs, Price Competition, And Consumers’ Welfare118 cited

2007Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration118 cited

2013Small Entrants and Large Incumbents: A Framework of Micro Entry117 cited

2013Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development98 cited

2011Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry96 cited

2005Games Hospitals Play: Entry Deterrence in Hospital Procedure Markets85 cited

2005Direct to consumer advertising in pharmaceutical markets83 cited